News in brief: Vitura signs MedReleaf deal; Neurotech initiates first site for Phase 3 autism trial by Adam Sheldon March 17, 2026March 17, 2026 Vitura Health has signed its first distribution agreement with MedReleaf Australia. Under the deal, MedReleaf – […]
Neurotech International announces breakthrough results from autism study by Martin Lane July 8, 2022April 29, 2024
